Day One Biopharmaceuticals (DAWN) began trading on the Nasdaq on Thur 27 May 21

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. 

• Sector(s): Healthcare
• Industry: Biotechnology
• Full Time Employees: 20
• Incorporated in 2018 
• Headquartered in South San Francisco, California
• http://dayonebio.com

Opened at $25 after pricing 10 mln share IPO at at $16.00 per share, at the high of the $14-16 expected range.

ticker: DAWN